Onco
>Best Oncologist
>Dr. Anil Kumar Aribandi
Dr. Anil Kumar Aribandi
Senior Haemato Oncologist
Qualifications:
MD
Expertise:
Hematologic Cancer
Practicing at:
American Oncology Institute, Hyderabad
Experience:
15 Years
Organ Specialization
- Blood
- Leukemia
- Multiple Myeloma
- Hodgkin's Lymphoma
- Non Hodgkin's Lymphoma
Publications
- Hyper - Nucleate Plasma Cell: A Rare Morphological Finding Gupta Anurag, Manu Goyal And Anil Aribandi Indian Journal Of Pathology And Microbiology (Accepted For Publication)
- Dose Escalation Study Of Bendamustine Based Conditioning Regime (Bace-Bendamustine, Cytarabine, Cyclophosphamide And Etoposide) In Patients With Lymphoma Undergoing Autologous Stem Cell Transplant Nidhi Dikshit,Rajani Sinha, Honey Maity, Nitin Sood, Anil Arabandi, Kasturi Sengupta And Joydeep Chakrabartty Hemat Transfus Int J 2017,5(5):00130
- Bendamustine-Based Conditioning Regime (BACE-Bendamustine, Cytarabine, Cyclophosphamide And Etoposide) For Patients With Lymphoma Undergoing Autologous Stem Cell Transplant. Joydeep Chakrabartty, Neelesh Jain, Pooja Sarada, Kasturi Sengupta, Nitin Sood, Anil Arabandi, Amrita Chakravarti, Amitabh Ray Biology Of Blood And Marrow Transplantation, Vol. 23, Issue 3, S133 March 2017(Abstract)
- Evaluation Of The Efficacy And Safety Of Darbepoetin Alfa In Reducing The Transfusion Requirements In Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation For Hematological Malignancies. Joydeep Chakrabartty, Neelesh Jain, Kasturi Sengupta, Debarghya Mukherjee, Pooja Sarada, Anil Aribandi, Nitin Sood, Amrita Chakravarti, . Biology Of Blood And Marrow Transplantation, Vol. 23, Issue 3, S133 March 2017(Abstract)
- Consensus In The Management Of Multiple Myeloma In India At Myeloma State Of The Art 2016 Conference. Anamandra, U., Khattry, N., Kumar, S., Raje, N., Jain, A., Jagannath, S., ... For IMAGe Group (2017)Indian Journal Of Hematology And Blood Transfusion, 1-7. Jan 2017
- Bendamustine Based Conditioning Regime (BACE-Bendamustine, Cytarabine, Cyclophosphamide And Etoposide) For Patients With Lymphoma Undergoing Autologous Stem Cell Transplant Neelesh Jain, Amrita Chakravarti, Nitin Sood, Anil Arabandi, Kasturi Sengupta, Joydeep Chakrabartty. Biology Of Blood And Marrow Transplantation, Vol. 22, Issue 3, S121–S122; March 2016
- Primary Lymphnode Plasmacytoma : A Case Report – Bloodmed.Com
Registration
- 37215Andhra Pradesh Medical Council
Education
- MBBS, Kakatiya Medical College, University Of Health Sciences(AP) - 1995
- MD (Medicine), Osmania General Hospital, NTR University Of Health Sciences (AP) - 2000
- MRCP, Royal College Of Physicians (UK) - 2005
- FRCPath, Royal College Of Pathologist S (UK)
- CCT, JRCPTB, CCT: Certificate Of Completion Of Specialist Training (Haematology)
Frequently asked questions
Where can I meet Dr. Anil Kumar Aribandi for consultation?
Dr. Anil Kumar Aribandi visits American Oncology Institute , Hyderabad. The doctor also provides teleconsultation via Onco. You can call 7996579965 7996579965 for this service.
How can I get an appointment with Dr. Anil Kumar Aribandi?
You can book a priority appointment with Dr. Anil Kumar Aribandi through us. Request a call back or call us on 7996579965 7996579965 .
What is Dr. Anil Kumar Aribandi’s speciality?
Dr. Anil Kumar Aribandi specialises in hemato oncology for hematologic cancer.
What medical qualification does Dr. Anil Kumar Aribandi have?
Dr. Anil Kumar Aribandi’s medical qualification is MD. You can also book an appointment with Dr. Anil Kumar Aribandi through Onco
How many years of experience does Dr. Anil Kumar Aribandi have?
Dr. Anil Kumar Aribandi has 15 years of experience in the field of hemato oncology for hematologic cancer.
How much does Dr. Anil Kumar Aribandi charge for consultation?
To know more accurate consultation fees, please get in touch with us.
Why should patients or care givers visit Dr. Anil Kumar Aribandi?
Patients or Care givers often visit Dr. Anil Kumar Aribandi for hematologic cancer. To get more information on reasons to visit Dr. Anil Kumar Aribandi, please visit Dr. Anil Kumar Aribandi profile on Onco